Pesquisas alternativas:
complex concept » complex concepts (Expandir a Pesquisa), complex context (Expandir a Pesquisa), complex connects (Expandir a Pesquisa)
ift complex » cst complex (Expandir a Pesquisa), joint complex (Expandir a Pesquisa), giant complex (Expandir a Pesquisa)
nano carlos » cano carlos (Expandir a Pesquisa), nino carlos (Expandir a Pesquisa), nuno carlos (Expandir a Pesquisa)
carlos nara » carlos lara (Expandir a Pesquisa), carlos nava (Expandir a Pesquisa), carlos jara (Expandir a Pesquisa)
hobbs john » hobbs jean (Expandir a Pesquisa)
nacl nano » nacl kno (Expandir a Pesquisa), nacl nabr (Expandir a Pesquisa), nacl naoh (Expandir a Pesquisa)
3.5 nacl » 0.9 nacl (Expandir a Pesquisa)
l hobbs » j hobbs (Expandir a Pesquisa), _ hobbs (Expandir a Pesquisa), m hobbs (Expandir a Pesquisa)
_ ift » _ ifn (Expandir a Pesquisa), _ ict (Expandir a Pesquisa)
complex concept » complex concepts (Expandir a Pesquisa), complex context (Expandir a Pesquisa), complex connects (Expandir a Pesquisa)
ift complex » cst complex (Expandir a Pesquisa), joint complex (Expandir a Pesquisa), giant complex (Expandir a Pesquisa)
nano carlos » cano carlos (Expandir a Pesquisa), nino carlos (Expandir a Pesquisa), nuno carlos (Expandir a Pesquisa)
carlos nara » carlos lara (Expandir a Pesquisa), carlos nava (Expandir a Pesquisa), carlos jara (Expandir a Pesquisa)
hobbs john » hobbs jean (Expandir a Pesquisa)
nacl nano » nacl kno (Expandir a Pesquisa), nacl nabr (Expandir a Pesquisa), nacl naoh (Expandir a Pesquisa)
3.5 nacl » 0.9 nacl (Expandir a Pesquisa)
l hobbs » j hobbs (Expandir a Pesquisa), _ hobbs (Expandir a Pesquisa), m hobbs (Expandir a Pesquisa)
_ ift » _ ifn (Expandir a Pesquisa), _ ict (Expandir a Pesquisa)
1
Por Ransom, Jason I., Powers, Jenny G., Thompson Hobbs, N., Baker, Dan L.
Publicado no J Appl Ecol (2014)
“... control efficacy. 3. Many population‐level studies demonstrate that changes in survival and immigration...”Publicado no J Appl Ecol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Stein, Brady L., Oh, Stephen T., Berenzon, Dmitriy, Hobbs, Gabriela S., Kremyanskaya, Marina, Rampal, Raajit K., Abboud, Camille N., Adler, Kenneth, Heaney, Mark L., Jabbour, Elias J., Komrokji, Rami S., Moliterno, Alison R., Ritchie, Ellen K., Rice, Lawrence, Mascarenhas, John, Hoffman, Ronald
Publicado no J Clin Oncol (2015)
Obter o texto integralPublicado no J Clin Oncol (2015)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Lopez, Derrick, Katzenellenbogen, Judith M, Sanfilippo, Frank M, Woods, John A, Hobbs, Michael S T, Knuiman, Matthew W, Briffa, Tom G, Thompson, Peter L, Thompson, Sandra C
Publicado em 2014
“... survivors of IHD emergency admission events (n =20,816) commencing at metropolitan hospitals in 2005–09...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Guo, Jing, Hobbs, Ditte A., Cockcroft, John R., Elwood, Peter C., Pickering, Janet E., Lovegrove, Julie A., Givens, David I.
Publicado no Eur J Nutr (2017)
“...), 1.39 (0.54, 3.56) and 2.87 (1.13, 7.27) for egg intake (n) of 0 ≤ n ≤ 1, 1 < n ≤ 2, 2 < n ≤ 3, 3 < n...”Publicado no Eur J Nutr (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Roalfe, Andrea K., Taylor, Clare J., Kelder, Johannes C., Hoes, Arno W., Hobbs, F.D. Richard
Publicado no ESC Heart Fail (2021)
“... to 83.4); the NICE threshold at 400 ng/L had summary NPV of 74.7% (72.1 to 77.2), PPV 81.8% (73.3 to 89.5...”Publicado no ESC Heart Fail (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Lutz, Sharon M, Frederiksen, Brittni, Begum, Ferdouse, McDonald, Merry-Lynn N, Cho, Michael H, Hobbs, Brian D, Parker, Margaret M, DeMeo, Dawn L, Hersh, Craig P, Ehringer, Marissa A, Young, Kendra, Jiang, Lai, Foreman, Marilyn G, Kinney, Greg L, Make, Barry J, Lomas, David A, Bakke, Per, Gulsvik, Amund, Crapo, James D, Silverman, Edwin K, Beaty, Terri H, Hokanson, John E
Publicado no Nicotine Tob Res (2018)
“... (β = 0.12, p = 3.86 × 10(−5)) For the gene-based exome array association analysis of rare variants...”Publicado no Nicotine Tob Res (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Fukuto, Jon M., Ignarro, Louis J., Nagy, Peter, Wink, David A., Kevil, Christopher G., Feelisch, Martin, Cortese‐Krott, Miriam M., Bianco, Christopher L., Kumagai, Yoshito, Hobbs, Adrian J., Lin, Joseph, Ida, Tomoaki, Akaike, Takaaki
Publicado no FEBS Lett (2018)
“...) and higher order polysulfur species (RSS(n)H, RSS(n)R, n > 1). Recent and provocative work has alluded...”Publicado no FEBS Lett (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Crane, Christopher H., Varadhachary, Gauri R., Yordy, John S., Staerkel, Gregg A., Javle, Milind M., Safran, Howard, Haque, Waqar, Hobbs, Bridgett D., Krishnan, Sunil, Fleming, Jason B., Das, Prajnan, Lee, Jeffrey E., Abbruzzese, James L., Wolff, Robert A.
Publicado em 2011
“... pancreatic cancer (LAPC). PATIENTS AND METHODS: Treatment-naive eligible patients (n = 69) received...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Lamarca, Angela, Palmer, Daniel H, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari, Anthoney, Alan, Maraveyas, Anthony, Iveson, Tim, Waters, Justin S, Hobbs, Claire, Barber, Safia, Ryder, W David, Ramage, John, Davies, Linda M, Bridgewater, John A, Valle, Juan W
Publicado no Lancet Oncol (2021)
“... months (95% CI 5·4–7·6) in the ASC plus FOLFOX group versus 5·3 months (4·1–5·8) in the ASC alone group...”Publicado no Lancet Oncol (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Sidana, Surbhi, Rajkumar, S. Vincent, Dispenzieri, Angela, Lacy, Martha Q., Gertz, Morie A., Buadi, Francis K., Hayman, Suzanne R., Dingli, David, Kapoor, Prashant, Gonsalves, Wilson I., Go, Ronald S., Hwa, Yi Lisa, Leung, Nelson, Fonder, Amie L., Hobbs, Miriam A., Zeldenrust, Steven R., Russell, Stephen J., Lust, John A., Kyle, Robert A., Kumar, Shaji K.
Publicado no Am J Hematol (2017)
“... symptoms in 64 (63%) patients, with purpura (n = 43, 42%) and ulcers/gangrene (n = 35, 34%) being most...”Publicado no Am J Hematol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Auyon J. Ghosh, Brian D. Hobbs, Jeong H. Yun, Aabida Saferali, Matthew Moll, Zhonghui Xu, Robert P. Chase, Jarrett Morrow, John Ziniti, Frank Sciurba, Lucas Barwick, Andrew H. Limper, Kevin Flaherty, Gerard Criner, Kevin K. Brown, Robert Wise, Fernando J. Martinez, Daniel McGoldrick, Michael H. Cho, Dawn L. DeMeo, Edwin K. Silverman, Peter J. Castaldi, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Craig P. Hersh
Publicado em 2022-04-01
“... performed RNA-sequencing on lung tissues from individuals with IPF (n = 231) and COPD (n = 377) compared...”Publicado em 2022-04-01
Obter o texto integral
Artigo
12
Por LaRovere, Kerri L., Riggs, Becky J., Poussaint, Tina Y., Young, Cameron C., Newhams, Margaret M., Maamari, Mia, Walker, Tracie C., Singh, Aalok R., Dapul, Heda, Hobbs, Charlotte V., McLaughlin, Gwenn E., Son, Mary Beth F., Maddux, Aline B., Clouser, Katharine N., Rowan, Courtney M., McGuire, John K., Fitzgerald, Julie C., Gertz, Shira J., Shein, Steven L., Munoz, Alvaro Coronado, Thomas, Neal J., Irby, Katherine, Levy, Emily R., Staat, Mary A., Tenforde, Mark W., Feldstein, Leora R., Halasa, Natasha B., Giuliano, John S., Hall, Mark W., Kong, Michele, Carroll, Christopher L., Schuster, Jennifer E., Doymaz, Sule, Loftis, Laura L., Tarquinio, Keiko M., Babbitt, Christopher J., Nofziger, Ryan A., Kleinman, Lawrence C., Keenaghan, Michael A., Cvijanovich, Natalie Z., Spinella, Philip C., Hume, Janet R., Wellnitz, Kari, Mack, Elizabeth H., Michelson, Kelly N., Flori, Heidi R., Patel, Manish M., Randolph, Adrienne G.
Publicado no JAMA Neurol (2021)
“... adjudicated to be associated with COVID-19, including severe encephalopathy (n = 15; 5 with splenial lesions...”Publicado no JAMA Neurol (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Lakshman, Arjun, Rajkumar, S. Vincent, Buadi, Francis K., Binder, Moritz, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Dingli, David, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Kapoor, Prashant, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.
Publicado no Blood Cancer J (2018)
“...% [hazard ratio (HR): 2.28 (CI, 1.63–3.20); p < 0.0001]; M-protein > 2g/dL [HR: 1.56 (CI, 1.11–2.20); p...”Publicado no Blood Cancer J (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Warsame, Rahma, LaPlant, Betsy, Kumar, Shaji K., Laumann, Kristina, Perez Burbano, Gabriela, Buadi, Francis K., Gertz, Morie A., Kyle, Robert A., Lacy, Martha Q., Dingli, David, Leung, Nelson, Hayman, Suzanne R., Kapoor, Prashant, Hwa, Yi L., Fonder, Amie, Hobbs, Miriam, Gonsalves, Wilson I., Kourelis, Taxiarchis, Lust, John, Russell, Stephen J., Zeldenrust, Steven, Lin, Yi, Muchtar, Eli, Go, Ronald S., Vincent Rajkumar, S., Dispenzieri, Angela
Publicado no Blood Cancer J (2020)
“.../progression criteria. Studies included were lenalidomide-dexamethasone (Len-Dex) (n = 37; years: 2004–2006...”Publicado no Blood Cancer J (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Charman, Sarah J., Okwose, Nduka C., Stefanetti, Renae J., Bailey, Kristian, Skinner, Jane, Ristic, Arsen, Seferovic, Petar M., Scott, Mike, Turley, Stephen, Fuat, Ahmet, Mant, Jonathan, Hobbs, Richard F.D., MacGowan, Guy A., Jakovljevic, Djordje G.
Publicado no ESC Heart Fail (2018)
“...; female, n = 18). Cardiac output was measured continuously using the bioreactance method in supine...”Publicado no ESC Heart Fail (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Mellors, Patrick W., Dasari, Surendra, Kohlhagen, Mindy C., Kourelis, Taxiarchis, Go, Ronald S., Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Buadi, Francis. K., Willrich, Maria A. V., Lust, John A., Kapoor, Prashant, Lacy, Martha Q., Dingli, David, Hwa, Yi, Fonder, Amie, Hobbs, Miriam, Hayman, Susan, Warsame, Rahma, Leung, Nelson R., Lin, Yi, Gonsalves, Wilson, Siddiqui, Mustaqeem, Kyle, Robert A., Rajkumar, S. Vincent, Murray, David L., Dispenzieri, Angela
Publicado no Blood Cancer J (2021)
“... to differentiate therapeutic monoclonal antibodies, and the rapid identification of light chain (LC) N...”Publicado no Blood Cancer J (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Moll, Matthew, Sakornsakolpat, Phuwanat, Shrine, Nick, Hobbs, Brian D, DeMeo, Dawn L, John, Catherine, Guyatt, Anna L, McGeachie, Michael J, Gharib, Sina A, Obeidat, Ma'en, Lahousse, Lies, Wijnant, Sara R A, Brusselle, Guy, Meyers, Deborah A, Bleecker, Eugene R, Li, Xingnan, Tal-Singer, Ruth, Manichaikul, Ani, Rich, Stephen S, Won, Sungho, Kim, Woo Jin, Do, Ah Ra, Washko, George R, Barr, R Graham, Psaty, Bruce M, Bartz, Traci M, Hansel, Nadia N, Barnes, Kathleen, Hokanson, John E, Crapo, James D, Lynch, David, Bakke, Per, Gulsvik, Amund, Hall, Ian P, Wain, Louise, Weiss, Scott T, Silverman, Edwin K, Dudbridge, Frank, Tobin, Martin D, Cho, Michael H
Publicado no Lancet Respir Med (2020)
“...) in European ancestry and 4·83 (3·45–6·77) in non-European ancestry cohorts. The polygenic risk score...”Publicado no Lancet Respir Med (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Lakshman, Arjun, Painuly, Utkarsh, Rajkumar, S. Vincent, Ketterling, Rhett P., Kapoor, Prashant, Greipp, Patricia T., Gertz, Morie A., Buadi, Francis K., Lacy, Martha Q., Dingli, David, Dispenzieri, Angela, Fonder, Amie L., Hayman, Suzanne R., Hobbs, Miriam A., Gonsalves, Wilson I., Hwa, Yi Lisa, Leung, Nelson, Go, Ronald S., Lin, Yi, Kourelis, Taxiarchis V., Warsame, Rahma, Lust, John A., Russell, Stephen J., Zeldenrust, Steven R., Kyle, Robert A., Kumar, Shaji K.
Publicado no Blood Cancer J (2019)
“...) detected by FISH to patients with high-risk translocations (HRT) (n = 79) and standard-risk (SR...”Publicado no Blood Cancer J (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Sidana, Surbhi, Tandon, Nidhi, Dispenzieri, Angela, Gertz, Morie A., Dingli, David, Jevremovic, Dragan, Morice, William G., Kapoor, Prashant, Kourelis, Taxiarchis V., Lacy, Martha Q., Hayman, Suzanne R., Buadi, Francis K., Leung, Nelson, Go, Ronald S., Lin, Yi, Russell, Stephen J., Lust, John A., Zeldenrust, Steven R., Warsame, Rahma, Hwa, Yi L., Hobbs, Miriam, Fonder, Amie, Kyle, Robert A., Rajkumar, S. Vincent, Kumar, Shaji K., Gonsalves, Wilson I.
Publicado no Leukemia (2018)
“... who underwent MFC, cPCs were detected in 42% (n = 65) patients. Median number of cPCs was 81 per 150...”Publicado no Leukemia (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Sweeting, M. J., Balm, R., Desgranges, P., Ulug, P., Powell, J. T., Balm, R., Koelemay, M. J. W., Idu, M. M., Kox, C., Legemate, D. A., Huisman, L. C., Willems, M. C. M., Reekers, J. A., van Delden, O. M., van Lienden, K. P., Hoornweg, L. L., Reimerink, J. J., van Beek, S. C., Vahl, A. C., Leijdekkers, V. J., Bosma, J., Montauban van Swijndregt, A. D., de Vries, C., van der Hulst, V. P. M., Peringa, J., Blomjous, J. G. A. M., Visser, M. J. T., van der Heijden, F. H. W. M., Wisselink, W., Hoksbergen, A. W. J., Blankensteijn, J. D., Visser, M. T. J., Coveliers, H. M. E., Nederhoed, J. H., van den Berg, F. G., van der Meijs, B. B., van den Oever, M. L. P., Lely, R. J., Meijerink, M. R., Voorwinde, A., Ultee, J. M., van Nieuwenhuizen, R. C., Dwars, B. J., Nagy, T. O. M., Tolenaar, P., Wiersema, A. M., Lawson, J. A., van Aken, P. J., Stigter, A. A., van den Broek, T. A. A., Vos, G. A., Mulder, W., Strating, R. P., Nio, D., Akkersdijk, G. J. M., van der Elst, A., Exter, P.van, Desgranges, P., Becquemin, J.‐P., Allaire, E., Cochennec, F., Marzelle, J., Louis, N., Schneider, J., Majewski, M., Castier, Y., Leseche, G., Francis, F., Steinmetz, E., Berne, J.‐P., Favier, C., Haulon, S., Koussa, M., Azzaoui, R., Piervito, D., Alimi, Y., Boufi, M., Hartung, O., Cerquetta, P., Amabile, P., Piquet, P., Penard, J., Demasi, M., Alric, P., Canaud, L., Berthet, J.‐P., Julia, P., Fabiani, J.‐N., Alsac, J. M., Gouny, P., Badra, A., Braesco, J., Favre, J.‐P., Albertini, J.‐N., Martinez, R., Hassen‐Khodja, R., Batt, M., Jean, E., Sosa, M., Declemy, S., Destrieux‐Garnier, L., Lermusiaux, P., Feugier, P., Powell, J. T., Ashleigh, R., Gomes, M., Greenhalgh, R. M., Grieve, R., Hinchliffe, R., Sweeting, M., Thompson, M. M., Thompson, S. G., Ulug, P., Cheshire, N. J., Boyle, J. R., Serracino‐Inglott, F., Smyth, J. V., Thompson, M. M., Hinchliffe, R. J., Bell, R., Wilson, N., Bown, M., Dennis, M., Davis, M., Ashleigh, R., Howell, S., Wyatt, M. G., Valenti, D., Bachoo, P., Walker, P., MacSweeney, S., Davies, J. N., Rittoo, D., Parvin, S. D., Yusuf, W., Nice, C., Chetter, I., Howard, A., Chong, P., Bhat, R., McLain, D., Gordon, A., Lane, I., Hobbs, S., Pillay, W., Rowlands, T., El‐Tahir, A., Asquith, J., Cavanagh, S., Dubois, L., Forbes, T. L.
Publicado no Br J Surg (2015)
“... rate across the three trials was 31·3 per cent for patients randomized to endovascular repair/strategy...”Publicado no Br J Surg (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo